People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

8 Oct 2015
Change (% chg)

$0.02 (+1.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Harrington, John 

Dr. John J. Harrington, Ph.D., is Executive Vice President, Chief Scientific Officer, Director of Athersys Inc. Dr. Harrington led the development of the RAGEĀ® technology, as well as its application for gene discovery, drug discovery and commercial protein production applications. He is a listed inventor on over 20 issued or pending United States patents, has authored numerous scientific publications, and has received numerous awards for his work, including being named one of the top international young scientists by MIT Technology Review in 2002. Dr. Harrington has overseen the therapeutic product development programs at Athersys since their inception, and is also focused on the clinical development and manufacturing of MultiStemĀ®. During his career, he has also held positions at Amgen and Scripps Clinic. He earned his B.A. in Biochemistry and Cell Biology from the University of California at San Diego and his Ph.D. in Cancer Biology from Stanford University.

Basic Compensation

Total Annual Compensation, USD 462,015
Restricted Stock Awards, USD 88,862
Long-Term Incentive Plans, USD --
All Other, USD 177,713
Fiscal Year Total, USD 728,590

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gil Bokkelen


William Lehmann


John Harrington


Robert Deans


Laura Campbell


Lee Babiss

As Of  30 Dec 2014
Search Stocks